Rogel Cancer Center: University of Michigan

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.rogelcancercenter.org

Clinical Trials

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

Not Applicable

Not yet recruiting

Conditions: Familial Adenomatous Polyposis

First Posted Date: 2024-10-15

Last Posted Date: 2024-12-19

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 32

Registration Number: NCT06641310

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 1

Not yet recruiting

Conditions: Castration-Resistant Prostate Carcinoma
Metastatic Prostate Adenocarcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Bone Scan
Procedure: Computed Tomography
Drug: Enzalutamide
Drug: Ruxolitinib

First Posted Date: 2024-09-27

Last Posted Date: 2025-01-10

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 39

Registration Number: NCT06616155

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial

Phase 2

Recruiting

Conditions: Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Breast Ductal Carcinoma In Situ
Localized Breast Carcinoma

Interventions: Procedure: Biospecimen Collection
Drug: Fezolinetant
Drug: Placebo Administration
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2024-09-27

Last Posted Date: 2024-11-20

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 36

Registration Number: NCT06617455

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma

Phase 2

Not yet recruiting

Conditions: Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Interventions: Procedure: Computed Tomography
Other: Digital Photography
Procedure: Magnetic Resonance Imaging
Biological: Pembrolizumab

First Posted Date: 2024-08-30

Last Posted Date: 2024-12-19

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 22

Registration Number: NCT06580054

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

Not Applicable

Recruiting

Conditions: Skin Basal Cell Carcinoma

Interventions: Other: Educational Activity
Other: Patient Observation
Other: Best Practice
Other: Survey Administration

First Posted Date: 2024-08-06

Last Posted Date: 2024-10-16

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 200

Registration Number: NCT06539468

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

Not Applicable

Recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Interventions: Procedure: Acupressure Therapy
Other: Internet-Based Intervention
Other: Interview
Other: Medical Device Usage and Evaluation
Other: Questionnaire Administration

First Posted Date: 2024-06-04

Last Posted Date: 2024-10-16

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 30

Registration Number: NCT06442891

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Early Phase 1

Recruiting

Conditions: Colorectal Neoplasia

Interventions: Drug: Omeprazole
Drug: Aspirin

First Posted Date: 2024-04-22

Last Posted Date: 2024-10-09

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 24

Registration Number: NCT06378398

Locations: 🇺🇸
The University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer

Phase 2

Not yet recruiting

Conditions: Urothelial Carcinoma

Interventions: Drug: Enfortumab vedotin
Drug: Pembrolizumab

First Posted Date: 2024-04-10

Last Posted Date: 2024-12-04

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 32

Registration Number: NCT06356155

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Phase 2

Recruiting

Conditions: HPV-Related Carcinoma
Oropharynx Cancer

Interventions: Radiation: Radiation
Drug: Platinum based chemotherapy

First Posted Date: 2024-01-31

Last Posted Date: 2024-01-31

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 20

Registration Number: NCT06234748

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer
Postmenopausal

Interventions: Other: Acupressure

First Posted Date: 2024-01-29

Last Posted Date: 2024-10-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 50

Registration Number: NCT06228768

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy